ArticleScientific reports2025
A comparison of sperm parameters DNA fragmentation and telomere length in testicular versus ejaculated spermatozoa.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While previous studies reported conflicting findings on DNA fragmentation in testicular versus ejaculated spermatozoa, this study aimed to perform a detailed analysis of testicular spermatozoa, evaluating sperm parameters and detailed morphology, DNA fragmentation, and relative telomere length across testicular and ejaculated spermatozoa. The study included 60 men in four groups: normozoospermic men (control), men with oligoasthenoteratozoospermia (OAT), men with a history of sperm presence in the semen who were candidates for conventional testicular sperm extraction (TESE), and non-obstructive azoospermia (NOA) patients undergoing microdissection testicular sperm extraction (M-TESE). Spermatozoa were evaluated for vitality (eosin staining), teratozoospermia Index (TZI) and detailed morphology (Diff-Quik staining), DNA fragmentation (sperm chromatin dispersion assay), and relative telomere length (q-PCR). The results demonstrated that sperm vitality was significantly lower in the OAT group. The control group showed markedly higher rate of normal morphology and lower TZI compared to the OAT, TESE, and M-TESE groups. The TESE and M-TESE groups showed higher rates of head-midpiece abnormalities and residual bodies compared to the control group (P < 0.0001, P < 0.0001, respectively). Sperm DNA fragmentation in the control group showed a significant decrease relative to all experimental groups (P < 0.0001). The control group demonstrated a significantly higher proportion of sperm with intact acrosomes than all experimental groups (P < 0.0001). Moreover, the relative sperm telomere length was markedly lower in the M-TESE group compared to the control (P = 0.0006), OAT, and TESE groups (P < 0.0001). Our results demonstrated that testicular sperm have significantly elevated DNA damage levels. Moreover, these spermatozoa exhibit increased frequencies of morphological abnormalities in the head and midpiece regions, reacted acrosomes, and residual bodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.